Go Pro
NYSEARCA:SBIO

ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News

ALPS Medical Breakthroughs ETF logo
$66.83 -0.26 (-0.39%)
As of 03:58 PM Eastern

About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Advanced

Key Stats

Today's Range
$65.65
$66.83
50-Day Range
$58.66
$70.79
52-Week Range
$34.66
$70.85
Volume
36,902 shs
Average Volume
37,864 shs
Market Capitalization
$211.85 million
Assets Under Management
$241.22 million
Dividend Yield
N/A
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

ALPS Medical Breakthroughs ETF Expenses

TypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.55%0.57%0.51%0.53%
Other Expenses0.00%0.52%0.53%0.60%0.54%
Total Expense0.50%0.76%0.75%0.75%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.77%-0.68%
Net Expense0.50%0.58%0.63%0.57%0.60%
Receive SBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SBIO ETF News Headlines

(SBIO) ALPS Medical Breakthroughs ETF
SBIO: Dividendenhistorie, Rendite und Ex-Dividenden-Tag
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
See More Headlines

SBIO ETF - Frequently Asked Questions

ALPS Medical Breakthroughs ETF's stock was trading at $51.22 on January 1st, 2026. Since then, SBIO shares have increased by 29.2% and is now trading at $66.20.

Top institutional investors of ALPS Medical Breakthroughs ETF include Fulcrum Equity Management (0.14%) and Harbor Investment Advisory LLC (0.02%).

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ALPS Medical Breakthroughs ETF investors own include Waste Connections (WCN), American Water Works (AWK), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
ALPS
Fund Name
ALPS Medical Breakthroughs ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:SBIO
Inception Date
12/30/2014
Fund Manager
Ryan Mischker, Andrew Hicks
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S-Network Medical Breakthroughs Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
109

Fund Statistics

Assets Under Management
$241.22 million
Average Daily Volume
$39.20 thousand
Discount/Premium
0.08%

Administrator, Advisor and Custodian

Administrator
ALPS Fund Services, Inc.
Advisor
ALPS Advisors, Inc.
Custodian
State Street Bank and Trust Company
Distributor
ALPS Distributors, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
Optionable
Options Volume
1
Put Options
0
Call Options
1
Short Interest
78,401 shs

Miscellaneous

Beta
0.74
Creation Unit
50,000
Creation Fee
$500.00
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

SBIO Sector Exposure

SBIO Industry Exposure


This page (NYSEARCA:SBIO) was last updated on 8/31/2026 by MarketBeat.com Staff.
From Our Partners